In this Section |
259710 Effectiveness of sequential brief interventions for tobacco and marijuana use among 18-24 year oldsTuesday, October 30, 2012
The prevalence of cigarette smoking (36%) and marijuana use (19%) among 18-24 year olds is higher than in any other age group in the US. Since 69% of young adult marijuana smokers also smoke cigarettes, there is reason to believe that the behaviors should be approached concomitantly. Using a two phase design, the aim of this RCT was to evaluate the effectiveness of sequential brief interventions (BI) for tobacco and marijuana use. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) was used to identify young adults for tobacco and risky marijuana use. 317 18-24 year old cigarette smokers scoring in the moderate risk level for marijuana use were recruited from a federally qualified dental clinic in inner-city Hartford, CT. Phase I: All participants received smoking cessation counseling (including 2 booster calls). Phase II: Participants were randomized into a control group, BI for marijuana use or BI plus 2 additional sessions of MET counseling for marijuana use. For both phases, the main outcomes were the ASSIST Tobacco and Marijuana Scores. Following smoking cessation counseling, participants' Marijuana Scores were significantly reduced from 20.11 (9.32) to 17.86 (9.93), n=268. Following brief intervention for marijuana use, there were no significant changes in the participants' Marijuana or Tobacco Scores for either treatment condition compared to the control group at the time of the two month follow-up (n=178) or six months later (n=174). The significance of the findings for clinical interventions is that opportunistic brief interventions with young adult marijuana users may not be effective.
Learning Areas:
Implementation of health education strategies, interventions and programsPublic health or related research Social and behavioral sciences Learning Objectives: Keywords: Smoking, Marijuana
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am qualified to present this work because I was involved in the development of the research protovol, the day-to-day coordination of the research activities and analysis of the data. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 4259.0: SBIRT Across Populations & Settings
|